{"symbol": "BLCM", "companyName": "Bellicum Pharmaceuticals Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.bellicum.com", "description": "Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.", "CEO": "Richard A. Fair", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}